The impact of infant Bacille Calmette-Guérin vaccination on the immunogenicity of other vaccines: a randomized exploratory study

The impact of infant Bacille Calmette-Guérin vaccination on the immunogenicity of other vaccines: a randomized exploratory study

The effect of the Bacille Calmette-Guérin (BCG) vaccine on the immunogenicity of separately administered serogroup C meningococcal vaccine and other vaccinations was examined in 28 infants randomized to receive BCG at age ≤7 days, at 3 months or after study completion. Immunogenicity of the serogrou...

Bibliografski detalji
Glavni autori:	Maytum, A, Porter, D, de Whalley, P, Thompson, A, Plested, E, Kerridge, S, Liu, X, Smits, G, van der Klis, F, Snape, MD, Clutterbuck, E, Pollard, AJ
Format:	Journal article
Jezik:	English
Izdano:	Wolters Kluwer 2024

Slični predmeti

Tuberculosis vaccines: beyond bacille Calmette–Guérin
od: McShane, H
Izdano: (2011)

Evaluation of the non-specific effects of Bacille Calmette-Guérin (BCG) vaccination in healthy UK adults
od: Wilkie, M
Izdano: (2019)

Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study
od: Fletcher, H, i dr.
Izdano: (2016)

Reactivation of the bacille Calmette-Guerin scar following immune reconstitution during treatment of infant acute lymphoblastic leukemia.
od: Swinson, S, i dr.
Izdano: (2004)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
od: McShane, H
Izdano: (2011)

Safety and immunogenicity of newborn MVA85A vaccination and selective, delayed Bacille Calmette-Guerin (BCG) for infants of HIV infected mothers: A phase 2 randomized controlled trial.
od: Nemes, E, i dr.
Izdano: (2017)

Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin.
od: Vordermeier, H, i dr.
Izdano: (2004)

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
od: Goonetilleke, N, i dr.
Izdano: (2003)

Implementation of universal newborn screening for severe combined immunodeficiency in Singapore while continuing routine Bacille-Calmette-Guerin vaccination given at birth
od: Chan, Bianca Su-Wan, i dr.
Izdano: (2022)

A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guérin
od: Minassian, A, i dr.
Izdano: (2012)

A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin.
od: Minassian, A, i dr.
Izdano: (2012)

Optimization of a human bacille Calmette-Guerin challenge model: a tool to evaluate antimycobacterial immunity
od: Minhinnick, A, i dr.
Izdano: (2015)

Migratory sub-populations of afferent lymphatic dendritic cells differ in their interactions with Mycobacterium bovis Bacille Calmette Guerin.
od: Hope, J, i dr.
Izdano: (2012)

Migratory sub-populations of afferent lymphatic dendritic cells differ in their interactions with Mycobacterium bovis Bacille Calmette Guerin
od: Hope, J, i dr.
Izdano: (2012)

Safety and immunogenicity of early Bacillus Calmette-Guérin vaccination in infants who are preterm and/or have low birth weights. A systematic review and meta-analysis
od: Badurdeen, S, i dr.
Izdano: (2018)

A randomised controlled trial of the effects of albendazole in pregnancy on maternal responses to mycobacterial antigens and infant responses to bacille Calmette-Guérin (BCG) immunisation [ISRCTN32849447]
od: Elliott, A, i dr.
Izdano: (2005)

Identification of N[superscript 6],N[superscript 6]-Dimethyladenosine in Transfer RNA from Mycobacterium bovis Bacille Calmette-Guérin
od: Chan, Tsz Yan Clement, i dr.
Izdano: (2014)

Minimal sex-differential modulation of reactivity to pathogens and toll-like receptor ligands following infant Bacillus Calmette–Guérin Russia vaccination
od: Darboe, F, i dr.
Izdano: (2017)

Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting
od: Dean, G, i dr.
Izdano: (2014)

Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting.
od: Dean, G, i dr.
Izdano: (2014)

Cloning, Expression And Immunogenicity Of Recombinant Bacille Calmette-Guerin (BCG) Containing T And B Cell Epitopes Of Mycobacterium Tuberculosis [QR82.M95 R737 2008 f rb].
od: Mohamud, Rohimah
Izdano: (2008)

Reiter's syndrome postintravesical Bacillus Calmette–Guérin instillations
od: Ng, K.L., i dr.
Izdano: (2017)

Altered memory T-cell responses to Bacillus Calmette-Guerin and Tetanus Toxoid vaccination and altered cytokine responses to polyclonal stimulation in HIV-exposed uninfected Kenyan infants
od: Garcia-Knight, M, i dr.
Izdano: (2015)

Using aerosol Bacille Calmette-Guérin in non-human primates to model the immune response to Mycobacterium Tuberculosis: a translational bridge between preclinical models and clinical trials
od: Hoogkamer, E
Izdano: (2022)

Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
od: Soleymani Majd, H
Izdano: (2022)

Immunogenicity and reactogenicity of a reduced schedule of a 4-component capsular group B meningococcal vaccine: a randomized controlled trial in infants
od: Valente Pinto, M, i dr.
Izdano: (2020)

Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
od: Perrett, K, i dr.
Izdano: (2009)

Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infants.
od: Collins, C, i dr.
Izdano: (2005)

Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial.
od: Diggle, L, i dr.
Izdano: (2006)

Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial
od: Diggle, L, i dr.
Izdano: (2006)

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.
od: Snape, MD, i dr.
Izdano: (2008)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose.
od: Snape, MD, i dr.
Izdano: (2013)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
od: Snape, M, i dr.
Izdano: (2013)

Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines - exploratory analyses within a randomised controlled trial
od: Khatami, A, i dr.
Izdano: (2014)

Divergent Memory B Cell Responses in a Mixed Infant Pneumococcal Conjugate Vaccine Schedule
od: Trück, J, i dr.
Izdano: (2016)

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants
od: Ruggeberg, J, i dr.
Izdano: (2007)

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants.
od: Ruggeberg, J, i dr.
Izdano: (2007)

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants
od: Ruggeberg, J, i dr.
Izdano: (2007)

A randomized trial assessing the immunogenicity and reactogenicity of two hexavalent infant vaccines concomitantly administered with group b meningococcal vaccine
od: Rajan, M, i dr.
Izdano: (2022)

Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.
od: Gossger, N, i dr.
Izdano: (2012)